U.S. Markets closed

GOLDEN MEDITECH (0801-OL.HK)


HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
Full screen
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Rangeundefined - undefined
VolumeN/A
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire2 months ago

    Golden Meditech Announces the Close of the Voluntary Conditional Cash Offer and Remains Public

    HONG KONG, April 10, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company"), a leading integrated healthcare enterprise in China, today announced that the voluntary conditional cash offer made by Mr. Kam Yuen, the Chairman, executive director and controlling shareholder of the Company, through his controlled company -- Magnum Opus 3 International Holdings Limited ("MO3") closed on 10 April 2017. As of today, valid acceptances of the cash offer have been received in respect of 968,774,034 shares (representing approximately 32.66% of the issued share capital and voting rights of the Company).

  • PR Newswire2 months ago

    Golden Meditech Announces the Close of the Voluntary Conditional Cash Offer and Remains Public

    HONG KONG, April 10, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company"), a leading integrated healthcare enterprise in China, today announced that the voluntary conditional cash offer made by Mr. Kam Yuen, the Chairman, executive director and controlling shareholder of the Company, through his controlled company -- Magnum Opus 3 International Holdings Limited ("MO3") closed on 10 April 2017. As of today, valid acceptances of the cash offer have been received in respect of 968,774,034 shares (representing approximately 32.66% of the issued share capital and voting rights of the Company).

  • PR Newswire3 months ago

    Golden Meditech Announces the Condition to the Voluntary Conditional Cash Offer Has Been Satisfied

    HONG KONG, March 15, 2017 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801, TWSE stock code: 910801) ("Golden Meditech" or the "Company"), a leading integrated healthcare enterprise in China, today announced that the shareholding ratio condition to the voluntary conditional cash offer made by Mr. Kam Yuen, the Chairman, executive director and controlling shareholder of the Company, through his controlled company -- Magnum Opus 3 International Holdings Limited ("MO3") has been satisfied, as a result, the voluntary conditional cash offer is now unconditional. As of today, valid acceptances of the cash offer have been received in respect of 460,817,868 shares (representing approximately 15.54% of the issued share capital and voting rights of the Company).